Search the collection

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Integrated exposure–response analysis of efficacy and safety of lurbinectedin to support the dose regimen in small-cell lung cancer
Author / Creator:Fernández-Teruel, Carlos ; Fudio, Salvador ; Lubomirov, Rubin
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:Cancer chemotherapy and pharmacology, 2022-05, Vol.89 (5), p.585-594
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Quantitative determination of lurbinectedin, its unbound fraction and its metabolites in human plasma utilizing ultra-performance LC–MS/MS
Author / Creator:King, Nicholas ; Garcia-Martinez, Soledad ; Alcaraz, Eider ; Grisalena, Alba ; Lubomirov, Rubin ; Altares, Raquel ; Fernandez-Teruel, Carlos ; Francesch, Andrés M. ; Avilés, Pablo M. ; Fudio, Salvador
Publisher:United States: Public Library of Science
Journal title:PloS one, 2023-03, Vol.18 (3), p.e0283783-e0283783
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
A phase I trial of lurbinectedin in combination with cisplatin in patients with advanced solid tumors
Author / Creator:Metaxas, Yannis ; Kahatt, Carmen ; Alfaro, Vicente ; Fudio, Salvador ; Zeaiter, Ali ; Plummer, Ruth ; Sessa, Cristiana ; Von Moos, Roger ; Forster, Martin ; Stathis, Anastasios
Publisher:New York: Springer US
Journal title:Investigational new drugs, 2022-02, Vol.40 (1), p.91-98
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
ArticlesPeer ReviewedFull Text
Pharmacokinetics and Safety of Lurbinectedin Administrated with Itraconazole in Cancer Patients: A Drug–Drug Interaction Study
Author / Creator:Moreno, Irene ; Hernández, Tatiana ; Calvo, Emiliano ; Fudio, Salvador ; Kahatt, Carmen ; Martínez, Sara ; Iglesias, Jorge Luis ; Calafati, Román Octavio ; Pérez-Ramos, Laura ; Montilla, Lola ; Zeaiter, Ali ; Lubomirov, Rubin
Publisher:Switzerland: MDPI AG
Journal title:Marine drugs, 2024-04, Vol.22 (4), p.178
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
ArticlesPeer ReviewedFull Text
CYP3A Genotype Is Associated With Variability in the Exposure and Clearance of the Novel Oncogenic Transcription Inhibitor Lurbinectedin
Author / Creator:Lubomirov, Rubin ; Pérez‐Ramos, Laura ; Fudio, Salvador ; Asín‐Prieto, Eduardo ; Ibarra‐Gómez, Laura ; Zubiaur, Pablo
Publisher:United States: John Wiley & Sons, Inc
Journal title:Clinical and translational science, 2025-04, Vol.18 (4), p.e70173-n/a
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 6
ArticlesPeer ReviewedFull Text
Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinectedin Pharmacokinetics and Safety in Patients with Advanced Solid Tumors: An Open-Label, Two-Way, Crossover, Phase Ib Drug–Drug Interaction St...
Author / Creator:Moreno, Irene ; Hernández, Tatiana ; Calvo, Emiliano ; Fudio, Salvador ; Kahatt, Carmen ; Fernández, Cristian ; Iglesias, Jorge Luis ; Corral, Gema ; Pérez-Ramos, Laura ; Montilla, Lola ; Zeaiter, Ali ; Lubomirov, Rubin
Publisher:Switzerland: MDPI AG
Journal title:Pharmaceuticals (Basel, Switzerland), 2024-01, Vol.17 (2), p.182
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 7
ArticlesPeer ReviewedFull Text
Effect of lurbinectedin on the QTc interval in patients with advanced solid tumors: an exposure–response analysis
Author / Creator:Fudio, Salvador ; Tabernero, Josep ; Subbiah, Vivek ; Chawla, Sant P. ; Moreno, Victor ; Longo, Federico ; Lopez, Rafael ; Anton, Antonio ; Trigo, Jose Manuel ; Shapiro, Geoffrey ; Jeong, Woondong ; Villalobos, Victor Manuel ; Lubomirov, Rubin ; Fernandez-Teruel, Carlos ; Alfaro, Vicente ; Boni, Valentina
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:Cancer chemotherapy and pharmacology, 2021-01, Vol.87 (1), p.113-124
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 8
ArticlesPeer ReviewedFull Text
Description and Modeling of Relevant Demographic and Laboratory Variables in a Large Oncology Cohort to Generate Virtual Populations
Author / Creator:Pérez-Ramos, Laura ; Ibarra-Gómez, Laura ; Lubomirov, Rubin ; García-Cremades, María ; Asín-Prieto, Eduardo ; Fudio, Salvador ; Zubiaur, Pablo
Publisher:Switzerland: MDPI AG
Journal title:Pharmaceutics, 2024-12, Vol.16 (12), p.1548
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 9
ArticlesPeer ReviewedFull Text
Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma
Author / Creator:Mateos, María Victoria ; Prosper, Felipe ; Martin Sánchez, Jesús ; Ocio, Enrique M. ; Oriol, Albert ; Motlló, Cristina ; Michot, Jean‐Marie ; Jarque, Isidro ; Iglesias, Rebeca ; Solé, María ; Martínez, Sara ; Kahatt, Carmen ; Fudio, Salvador ; Corral, Gema ; Zeaiter, Ali ; Montilla, Lola ; Ribrag, Vincent
Publisher:United States: John Wiley & Sons, Inc
Journal title:Cancer medicine (Malden, MA), 2023-02, Vol.12 (4), p.3999-4009
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 10
ArticlesPeer ReviewedFull Text
Anti-cancer drug combinations approved by US FDA from 2011 to 2021: main design features of clinical trials and role of pharmacokinetics
Author / Creator:Fudio, Salvador ; Sellers, Alvaro ; Pérez Ramos, Laura ; Gil-Alberdi, Beatriz ; Zeaiter, Ali ; Urroz, Mikel ; Carcas, Antonio ; Lubomirov, Rubin
Publisher:Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title:Cancer chemotherapy and pharmacology, 2022-10, Vol.90 (4), p.285-299
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 11
ArticlesPeer ReviewedFull Text
Population-Pharmacokinetic and Covariate Analysis of Lurbinectedin (PM01183), a New RNA Polymerase II Inhibitor, in Pooled Phase I/II Trials in Patients with Cancer
Author / Creator:Fernandez-Teruel, Carlos ; Gonzalez, Ignacio ; Trocóniz, Iñaki F. ; Lubomirov, Rubin ; Soto, Arturo ; Fudio, Salvador
Publisher:Cham: Springer International Publishing
Journal title:Clinical pharmacokinetics, 2019-03, Vol.58 (3), p.363-374
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 12
ArticlesPeer ReviewedFull Text
First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors
Author / Creator:Elez, Elena ; Gomez-Roca, Carlos ; Soto Matos-Pita, Arturo ; Argiles, Guillem ; Valentin, Thibaud ; Coronado, Cinthya ; Iglesias, Jorge ; Macarulla, Teresa ; Betrian, Sarah ; Fudio, Salvador ; Zaragoza, Katrin ; Tabernero, Josep ; Delord, Jean-Pierre
Publisher:New York: Springer US
Journal title:Investigational new drugs, 2019-08, Vol.37 (4), p.674-683
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 13
ArticlesPeer ReviewedFull Text
Quantitative determination of lurbinectedin, its unbound fraction and its metabolites in human plasma utilizing ultra-performance LC–MS/MS Quantitative determination of lurbinectedin, its unbound frac...
Author / Creator:Nicholas King ; Soledad Garcia-Martinez ; Eider Alcaraz ; Alba Grisalena ; Rubin Lubomirov ; Raquel Altares ; Carlos Fernandez-Teruel ; Andrés M. Francesch ; Pablo M. Avilés ; Salvador Fudio
Publisher:Public Library of Science (PLoS)
Journal title:PloS one, 2023-01, Vol.18 (3)
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Export record to excel

Export this record

Export record to excel

Integrated exposure–response analysis of efficacy and safety of lurbinectedin to support the dose regimen in small-cell lung cancer

Export this record

Export record to excel

Quantitative determination of lurbinectedin, its unbound fraction and its metabolites in human plasma utilizing ultra-performance LC–MS/MS

Export this record

Export record to excel

A phase I trial of lurbinectedin in combination with cisplatin in patients with advanced solid tumors

Export this record

Export record to excel

Pharmacokinetics and Safety of Lurbinectedin Administrated with Itraconazole in Cancer Patients: A Drug–Drug Interaction Study

Export this record

Export record to excel

CYP3A Genotype Is Associated With Variability in the Exposure and Clearance of the Novel Oncogenic Transcription Inhibitor Lurbinectedin

Export this record

Export record to excel

Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinectedin Pharmacokinetics and Safety in Patients with Advanced Solid Tumors: An Open-Label, Two-Way, Crossover, Phase Ib Drug–Drug Interaction St...

Export this record

Export record to excel

Effect of lurbinectedin on the QTc interval in patients with advanced solid tumors: an exposure–response analysis

Export this record

Export record to excel

Description and Modeling of Relevant Demographic and Laboratory Variables in a Large Oncology Cohort to Generate Virtual Populations

Export this record

Export record to excel

Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma

Export this record

Export record to excel

Anti-cancer drug combinations approved by US FDA from 2011 to 2021: main design features of clinical trials and role of pharmacokinetics

Export this record

Export record to excel

Population-Pharmacokinetic and Covariate Analysis of Lurbinectedin (PM01183), a New RNA Polymerase II Inhibitor, in Pooled Phase I/II Trials in Patients with Cancer

Export this record

Export record to excel

First-in-human phase I study of the microtubule inhibitor plocabulin in patients with advanced solid tumors

Export this record

Export record to excel

Quantitative determination of lurbinectedin, its unbound fraction and its metabolites in human plasma utilizing ultra-performance LC–MS/MS Quantitative determination of lurbinectedin, its unbound frac...

Refine your search